Z Gastroenterol 2020; 58(03): e71
DOI: 10.1055/a-1143-8420
Erratum

Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

D Pfister
1   DKFZ, F180-Chronic Inflammation and Cancer, Heidelberg, Germany
,
N Nunez
2   UZH, Institute of Experimental Immunology, Zurich, Switzerland
,
A Sinha
3   MPI of Biochemistry, Experimental Systems Immunology, Martinsried, Germany
,
A Weiner
4   Weizmann Institute of Science, Department of Immunology, Rehovot, Israel
,
A Deczkowska
4   Weizmann Institute of Science, Department of Immunology, Rehovot, Israel
,
M Pinter
5   Medical University of Vienna, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Vienna, Austria
,
O Govaere
6   The Medical School, Newcastle University, Institute of Cellular Medicine, Newcastle, United Kingdom
,
F Müller
1   DKFZ, F180-Chronic Inflammation and Cancer, Heidelberg, Germany
,
Q M Anstee
6   The Medical School, Newcastle University, Institute of Cellular Medicine, Newcastle, United Kingdom
,
T Entgleitner
7   TUM, Department of Medicine II, Munich, Germany
,
R Rad
7   TUM, Department of Medicine II, Munich, Germany
,
R Pinyol
8   Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clínic, Universitat de Barcelona, Liver Cancer Translational Research Laboratory, Barcelona, Spain
,
S Torrecilla
8   Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clínic, Universitat de Barcelona, Liver Cancer Translational Research Laboratory, Barcelona, Spain
,
M Dudek
9   TUM, Institute of Molecular Immunology and Experimental Oncology, Munich, Germany
,
P Knolle
9   TUM, Institute of Molecular Immunology and Experimental Oncology, Munich, Germany
,
A Weber
10   University Zurich, Institute for Molecular Pathology, Zurich, Switzerland
,
D Lengenhagger
10   University Zurich, Institute for Molecular Pathology, Zurich, Switzerland
,
J M Llovet
8   Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clínic, Universitat de Barcelona, Liver Cancer Translational Research Laboratory, Barcelona, Spain
,
I Amit
4   Weizmann Institute of Science, Department of Immunology, Rehovot, Israel
,
F Meissner
3   MPI of Biochemistry, Experimental Systems Immunology, Martinsried, Germany
,
B Becher
2   UZH, Institute of Experimental Immunology, Zurich, Switzerland
,
M Heikenwälder
1   DKFZ, F180-Chronic Inflammation and Cancer, Heidelberg, Germany
› Author Affiliations


Publication History

Article published online:
24 March 2020

© Georg Thieme Verlag KG
Stuttgart · New York